Appeal No. 1997-1954
Application 08/154,903
The remaining claims, claims 6 and 8 through 17, should be separately considered
by the examiner in light of the disclosures of Short and Frohn. These claims require
specific melatonin analogs. The examiner should consider the remaining melatonin
analogs described by Frohn and determine whether they fall within the scope of the
remaining claims.
REVERSED; REMANDED
)
Sherman D. Winters )
Administrative Patent Judge )
)
)
) BOARD OF PATENT
William F. Smith )
Administrative Patent Judge ) APPEALS AND
)
) INTERFERENCES
)
Fred E. McKelvey, Senior )
Administrative Patent Judge )
WFS/cam
9
Page: Previous 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007